Allostery Investments LP Apellis Pharmaceuticals, Inc. Transaction History
Allostery Investments LP
- $95.7 Billion
- Q4 2024
A detailed history of Allostery Investments LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Allostery Investments LP holds 80,000 shares of APLS stock, worth $2.27 Million. This represents 2.67% of its overall portfolio holdings.
Number of Shares
80,000Holding current value
$2.27 Million% of portfolio
2.67%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$347 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$338 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$335 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$285 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$273 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.12B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...